THE JORDANIAN PHARMACEUTICAL MANUFACTURING Financial
Trading Information in the Regular Market
| 2020 | 2019 | 2018 | |
|---|---|---|---|
| Par Value/Share (JD) | 1.00 | 1.00 | 1.00 |
| Closing Price (JD) | 0.24 | 0.27 | 0.49 |
| Value Traded (JD) | 428,709 | 225,687 | 583,845 |
| No. of Shares Traded | 1,398,780 | 632,989 | 1,527,080 |
| No. of Transactions | 855 | 656 | 1,520 |
| No. of Subscribed Shares | 25,312,500 | 25,312,500 | 25,312,500 |
| Market Capitalization (JD) | 6,075,000 | 6,834,375 | 12,403,125 |
| Fiscal Year Ended | 31/12/2020 | 31/12/2019 | 31/12/2018 |
Assets (JD)
| 2020 | 2019 | 2018 | |
|---|---|---|---|
| Cash on Hand & at Banks | 208,409 | 450,693 | 238,473 |
| Accounts Receivable, Net | 16,156,313 | 14,111,224 | 20,930,467 |
| Notes Receivable | 0 | 0 | 0 |
| Post Dated Cheques | 467,681 | 743,295 | 703,790 |
| Short Term Investments | 0 | 0 | 0 |
| Inventory | 6,104,847 | 5,773,312 | 5,040,464 |
| Spare Parts | 0 | 0 | 0 |
| Total Current Assets | 23,683,990 | 21,763,400 | 27,428,765 |
| Long Term Investments | 3,268,061 | 3,152,726 | 4,093,265 |
| Fixed Assets, Net | 3,058,720 | 3,304,350 | 3,316,875 |
| Lands | 490,127 | 490,127 | 490,127 |
| Projects in Progress | 0 | 0 | 0 |
| Total Fixed Assets | 3,548,847 | 3,794,477 | 3,807,002 |
| Other Assets | 9,753,136 | 9,974,851 | 10,240,839 |
| Total Assets | 40,254,034 | 38,685,454 | 45,569,871 |
Liabilities (JD)
| 2020 | 2019 | 2018 | |
|---|---|---|---|
| Accounts and Notes Payable | 4,243,437 | 4,765,668 | 11,542,391 |
| Credit Banks | 955,811 | 949,830 | 707,156 |
| Short Term Loans | 0 | 0 | 7,261,346 |
| Accrued Part of Long Term Loans | 6,308,732 | 1,646,897 | 0 |
| Total Current Liabilities | 24,099,213 | 15,308,346 | 20,079,503 |
| Long Term Loans & Notes Payable | 17,554,740 | 12,554,500 | 5,067,524 |
| Corporate Bonds | 0 | 0 | 0 |
| Other Liabilities | 8,717,110 | 9,220,667 | 11,481,991 |
| Total Liabilities | 50,371,063 | 37,083,513 | 36,629,018 |
Income Statement (JD)
| 2020 | 2019 | 2018 | |
|---|---|---|---|
| Operating Revenues | 14,414,141 | 9,977,197 | 22,205,163 |
| Operating Expenses | 9,311,891 | 7,076,480 | 12,445,255 |
| Gross Profit | 5,102,250 | 2,900,717 | 9,759,908 |
| General and Administrative Expenses | 2,995,806 | 2,320,621 | 2,527,565 |
| Selling and Distribution Expenses | 4,092,784 | 5,285,945 | 5,434,794 |
| Depreciation (Period) | 713,329 | 740,631 | 643,028 |
| Other Operating Expenses | 970,419 | 1,918,111 | 4,100,900 |
| Net Operating Income | -2,956,759 | -6,623,960 | -2,303,351 |
| Other Revenues | 657,838 | 2,033,120 | 135,305 |
| Other Expenses | 5,804,181 | 169,061 | 93,956 |
| Income Before Interest & Tax | -8,103,102 | -4,759,901 | -2,262,002 |
| Interest Expenses | 1,476,031 | 1,147,462 | 1,800,182 |
| Net Income Before Tax | -9,579,133 | -5,907,363 | -4,062,184 |
| Income Tax (Period) | 2,104,406 | 6,563 | 51,293 |
| Income Tax (Previous Years) | 0 | 0 | 0 |
| Universities and Research Train Fees | 0 | 0 | 0 |
| Board of Directors Remuniration | 0 | 0 | 0 |
| Net Income | -11,683,539 | -5,913,926 | -4,113,477 |
| Non-controlling Interest | -46,553 | -54,588 | -17,437 |
| Net Income Pertains to Shareholders | -11,636,986 | -5,859,338 | -4,096,040 |
Cash Flow (JD)
| 2020 | 2019 | 2018 | |
|---|---|---|---|
| Cash Balance (Beginning) | -499,137 | -468,683 | 516,277 |
| Net Cash Flow from (Used in) Operating Activities | -9,470,214 | -443,740 | -1,863,269 |
| Net Cash Flow from (Used in) Investing Activities | -246,639 | -17,386 | -565,111 |
| Net Cash Flow from (Used in) Financing Activities | 9,468,588 | 430,672 | 1,443,420 |
| Cash Balance (Ending) | -747,402 | -499,137 | -468,683 |
Financial Ratios
| 2020 | 2019 | 2018 | |
|---|---|---|---|
| Turnover Ratio % | 5.526 | 2.501 | 6.033 |
| Earning Per Share (JD) | -0.460 | -0.232 | -0.162 |
| Dividend Per Share (JD) | 0.000 | 0.000 | 0.000 |
| Book Value Per Share (JD) | -0.405 | 0.056 | 0.344 |
| Price Earnings Ratio (Times) | -0.522 | -1.166 | -3.028 |
| Dividend Yield % | 0.000 | 0.000 | 0.000 |
| Dividend Per Share to Earning Per Share % | 0.000 | 0.000 | 0.000 |
| Price to Book Value (Times) | -0.593 | 4.812 | 1.425 |
| Gross Margin % | 35.398 | 29.074 | 43.953 |
| Margin Before Interest and Tax % | -56.216 | -47.708 | -10.187 |
| Profit Margin % | -81.056 | -59.274 | -18.525 |
| Return On Assets % | -29.025 | -15.287 | -9.027 |
| Return On Equity % | 113.507 | -412.570 | -47.058 |
| Debt Ratio % | 125.133 | 95.859 | 80.380 |
| Equity Ratio % | -25.133 | 4.141 | 19.620 |
| Interest Coverage Ratio (Times) | -5.490 | -4.148 | -1.257 |
| Total Assets Turnover (Times) | 0.358 | 0.258 | 0.487 |
| Fixed Assets Turnover (Times) | 4.062 | 2.629 | 5.833 |
| Working Capital Turnover (Times) | -34.714 | 1.546 | 3.021 |
| Current Ratio (Times) | 0.983 | 1.422 | 1.366 |
| Working Capital (JD) | -415,223.000 | 6,455,054.000 | 7,349,262.000 |